InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,064.20
(
0.91%
)
US TECH 100
17,146.00
(
1.69%
)
Dow Jones
38,225.66
(
0.85%
)
Brent Oil
83.61
(
0.08%
)
Bitcoin
58,902.11
(
1.14%
)

Schering AG (fka SRNGF)

0
Follow
0

Schering AG (fka SRNGF)

0
Follow
0

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up

Schering AG (fka SRNGF) RSS Feed

Followers
0
Posters
1
Posts (Today)
0
Posts (Total)
2
Created
07/25/06
Type
Free
Moderators
ABOUT Schering AG Schering AG is a research-based pharmaceutical company. Its activities are focused on four business areas: Gynecology&Andrology, Oncology, Diagnostic Imaging as well as Specialized Therapeutics for disabling diseases. As a global player with innovative products Schering AG aims for leading positions in specialized markets worldwide. With in-house R&D and supported by an excellent global network of external partners, Schering AG is securing a promising product pipeline. Using new ideas, Schering AG aims to make a recognized contribution to medical progress and strives to improve the quality of life: making medicine work COMPANY WEBSITE http://www.schering.de/scripts/en/index.php INVESTOR RELATIONS Berlin, Germany Peter Vogt Head of Investor Relations phone +49-30-46 81 28 38 fax +49-30-46 81 66 46 Dr. Jost Reinhard Investor Relations Manager phone +49-30-46 81 50 62 fax +49-30-46 81 66 46 USA/Canada Joanne Marion Montville, USA Investor Relations Director for USA/Canada phone +1-973-4 87 21 64 fax +1-973-4 87 20 05
Board Info
Posts Today
0
Posts (Total)
2
Posters
1
Moderators
New Post